Lilly’s pancreatic cancer treatment fails late-stage study
FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the…
U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta
(Reuters) – The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of…
Eli Lilly’s hypoglycemia treatment wins FDA approval
FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the…
FDA approves Lilly’s migraine drug as first ever cluster headache treatment
NEW YORK (Reuters) – Eli Lilly and Co’s migraine treatment Emgality on Tuesday became the first drug to gain U.S.…
Eli Lilly seeks to quell drug price anger with cheaper insulin
(Reuters) – Drugmaker Eli Lilly announced plans on Monday to sell a half-price version of its popular insulin injection Humalog,…
Lilly’s diabetes drug data impresses, hurts rival Novo’s shares
(Reuters) – Eli Lilly and Co (LLY.N) said on Thursday its new two-in-one diabetes drug was successful in lowering blood…
U.S. District Court rules in favor of Lilly’s Alimta patent
(Reuters) – Eli Lilly and Co said on Friday a U.S. District Court ruled in favor of its patent on…
VISUAL SIGNATURES: featuring Charles Lilly
VISUAL SIGNATURES is a Public Service Announcement (PSA) that highlights a vast cultural array of visual artists who share with…
Lilly’s Cyramza succeeds in late-stage liver cancer trial
(Reuters) – Eli Lilly and Co on Wednesday said its drug Cyramza met the main goal of helping patients live…